INFeD (Iron Dextran Complex) 50 mg is an injectable medication used to treat iron deficiency anemia when oral iron supplements are ineffective or cannot be used. It works by replenishing iron stores in the body, which is essential for producing hemoglobin and healthy red blood cells. INFeD is typically administered under the supervision of a healthcare professional, and the dosage is determined based on the patient's specific needs and condition.
Iron dextran is a complex of iron and the sugar dextran. When injected into the body, it is broken down into iron and dextran molecules. The iron component is then transported to the bone marrow, where it is used to produce hemoglobin, the protein in red blood cells that carries oxygen.
In individuals with iron deficiency anemia, there is a lack of iron available for red blood cell production. This can be due to insufficient dietary intake of iron, poor absorption of iron from the diet, or increased demands for iron (such as during pregnancy). By providing a source of iron directly into the body, INFeD helps to correct the iron deficiency and increase the production of red blood cells.
INFeD is typically given as an injection into a muscle or vein and is usually prescribed for several weeks to replenish iron stores and improve anemia symptoms. It is important to continue taking iron supplements or consuming iron-rich foods, as INFeD only provides a temporary boost of iron and does not address the underlying cause of iron deficiency.
Product Details and Features:
-
Effective Iron Supplementation: Each 2 mL vial contains 50 mg of elemental iron, designed to address iron deficiency anemia efficiently.
-
Parenteral Administration: Offers an alternative for patients unable to tolerate oral iron supplements.
-
Single-Dose Vials: Convenient packaging ensures accurate dosing and reduces the risk of contamination.
-
Trusted Manufacturer: Produced by Allergan Pharmaceuticals, guaranteeing quality and reliability.
Mechanism of Action:
INFeD Iron Dextran Complex works by providing elemental iron directly into the bloodstream, bypassing the gastrointestinal tract. This allows for rapid replenishment of iron stores, facilitating the production of hemoglobin and red blood cells, thus improving oxygen transport and energy levels.
Directions for Use:
-
Preparation: Inspect the vial for any particulate matter or discoloration prior to use.
-
Administration: Administer as an intravenous infusion or intramuscular injection as per healthcare provider instructions. Ensure proper aseptic technique.
-
Dosage: Follow the prescribed dosage regimen by your healthcare provider.
-
Aftercare: Monitor the patient post-infusion or injection for any adverse reactions.
Warnings:
- Only to be administered under the supervision of a healthcare professional.
- Patients with a known hypersensitivity to iron dextran should not use this product.
- Conduct a test dose prior to administering a full dose to assess potential allergic reactions.
- Use with caution in patients with a history of allergies or asthma.
Side Effects:
- Common side effects may include pain at the injection site, headache, dizziness, nausea, or flushing.
- Serious side effects can occur, such as anaphylactic reactions, hypotension, or severe dizziness. Immediate medical attention is required in such cases.
Choose INFeD Iron Dextran Complex for a reliable and trusted solution to managing iron deficiency anemia, ensuring the highest standards of care and efficacy for your patients.
- Primary Indication: Iron deficiency anemia where oral iron has failed or is not clinically viable — including patients with GI malabsorption, post-bariatric surgery, chronic kidney disease, or significant intolerance to oral formulations
- Total Dose Infusion: Iron dextran supports total dose infusion in a single session (calculated per patient weight and hemoglobin deficit); this is not available with all IV iron formulations and is a clinically relevant advantage in high-volume or resource-constrained settings
- Dialysis & Nephrology: Appropriate for patients on erythropoiesis-stimulating agents (ESAs) requiring concurrent parenteral iron to support red blood cell production
- Obstetric & Gynecologic Use: Suitable for pregnancy-related iron deficiency anemia when oral iron is insufficient or not tolerated, under supervising physician direction
- IV Therapy & Infusion Clinic Use: Licensed infusion clinics and medspas offering iron infusion services must ensure supervising provider availability, test dose administration, and anaphylaxis preparedness prior to use
- Dose Calculation: Total iron dose (mg) is calculated using patient body weight (kg) and hemoglobin deficit; at 50 mg elemental iron per vial, quantity requirements should be calculated per patient before ordering
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
- Test Dose Required: A test dose of 25 mg iron dextran (0.5 mL) must be administered and the patient monitored for a minimum of 30–60 minutes prior to any therapeutic dose; anaphylactic reactions have been reported at the test dose stage
- Anaphylaxis Risk: Serious, potentially fatal anaphylactic-type reactions have been reported with iron dextran injection; resuscitative equipment and trained personnel must be immediately available during every administration
- Contraindications: Do not use in patients with known hypersensitivity to iron dextran or any component of the formulation; not indicated for anemias not caused by iron deficiency
- High-Risk Populations: Use with caution in patients with a history of significant drug allergies, asthma, or immune-mediated conditions — these patients carry a higher risk of hypersensitivity reactions
- Common Side Effects: Injection site pain, headache, dizziness, nausea, and flushing are among the commonly reported adverse effects
- Serious Adverse Events: Hypotension, severe dizziness, respiratory distress, and anaphylaxis require immediate medical intervention; do not administer in settings lacking emergency response capability
- IM Administration Note: Intramuscular injection must use the Z-track technique to prevent permanent subcutaneous iron staining; IM injection into the deltoid or other exposed or inadequately muscled sites is not recommended
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
For Licensed Healthcare Professionals Only. INFeD Iron Dextran Injection (Iron Dextran Complex, 50 mg/2 mL) is a prescription-only (Rx) medication. Purchase, possession, and administration are restricted to individuals and entities holding a valid medical licence under applicable US federal and state law.
The clinical information provided on this page is intended as a general reference for licensed healthcare professionals and is not a substitute for the full INFeD prescribing information issued by Allergan Pharmaceuticals. Prescribers and administrators must consult the current FDA-approved prescribing information prior to use.
This product is not intended for self-administration, consumer purchase, or use without the direct supervision of a qualified healthcare provider. Mountainside Medical does not provide medical advice, diagnosis, or treatment recommendations. All clinical decisions regarding the use of this product remain the sole responsibility of the treating healthcare professional.
Product availability, pricing, and specifications are subject to change. Contact sales@mountainside-medical.com or call +1 (888) 687-4334 for current stock and pricing information.